Skip to main content

SUM · NZX

Summerset Group Holdings (SUM)

Healthcare / Retirement livingCovered: FY22 - HY268 published briefings

Summerset Group Holdings is an NZX-listed healthcare / retirement living company. Its latest covered result is HY26, with FY22 - HY26 of source-backed result history on Annolyse.

Latest result

Latest metrics

HY26, released 27 August 2026

← Swipe to view more
SUM latest metrics
MetricValueChange
Revenue$200.3m↑ +15.7%
EBITDA$140.5m↑ +3.5%
NPAT$171.4m↑ +34.7%
Operating cash flow$279.9m↑ +22.4%
OCF / EBITDA %199.2%↑ +30.8pp
Net debt$2.1b↑ +11.3%
Net debt / EBITDA14.65x↑ +7.6%
ROE %4.9%↑ +0.9pp
DPS3.8c↓ -66.4%
Payout ratio vs NPAT %5.4%Outside range low payout ratio versus npat. 5.4%; 3-period range 19.7% to 26%. Payout ratio versus NPAT: 5.4%, below normal range; 3-period mean 22.3%, range 19.7%-26.0%.↓ -15.9pp

Source: latest published briefing (HY26, released 27 August 2026). Change compares against the prior equivalent period: HY25, released 28 August 2025.

Valuation

Valuation

Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.

Prices as at close, 20 November 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$1.4b

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

4.67x

i

Recent market cap compared with trailing earnings.

EPS

1.24

i

Recent filing-derived earnings per share.

PEG

0.13x

i

P/E compared with recent earnings growth.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

6.72x

i

Market cap compared with recent free cash flow.

P/B

0.4x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

2.9%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

P/E over time

Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.

Loading chart...

Ask about SUM

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Financial history

Performance over time

The latest period is shown first.

← Swipe to view more
SUM metric history
MetricHY266 MONTHS27 August 2026FY2512 MONTHS27 February 2026HY256 MONTHS28 August 2025FY2412 MONTHS28 February 2025HY246 MONTHS26 August 2024FY2312 MONTHS26 February 2024HY236 MONTHS23 August 2023FY2212 MONTHS24 February 2023Trend
Revenue$200.3m$361.8m$173m$319.9m$151.6m$272.2m$128.2m$238.7m
Chart
Revenue growth %15.7%13.1%Outside range low revenue growth. 13.1%; 3-period range 14% to 17.5%. Revenue growth: 13.1%, below normal range; 3-period mean 15.9%, range 14.0%-17.5%.14.1%17.5%18.2%14.0%12.4%16.2%
Chart
  • FY25 Revenue growth %: Outside range low revenue growth. 13.1%; 3-period range 14% to 17.5%. Revenue growth: 13.1%, below normal range; 3-period mean 15.9%, range 14.0%-17.5%.
EBITDA$140.5m—$135.8m$382.1m$133.5m$450m$140.7m$282.1m
Chart
EBITDA margin %70.2%—78.5%119.4%88.0%165.3%109.7%118.2%
Chart
PBT$179.1m$241.1m$109.8m$355.8m$120.8m$422.5m$128.1m$265.1m
Chart
PBT growth %63.1%Outside range high pbt growth. 63.1%; 3-period range -9.1% to -5%. PBT growth: 63.1%, above normal range; 3-period mean -6.6%, range -9.1%--5.0%.-32.2%-9.1%-15.8%-5.7%59.4%-5.0%-51.2%
Chart
  • HY26 PBT growth %: Outside range high pbt growth. 63.1%; 3-period range -9.1% to -5%. PBT growth: 63.1%, above normal range; 3-period mean -6.6%, range -9.1%--5.0%.
NPAT$171.4m$259.7m$127.2m$339.8m$102.2m$436.3m$133.1m$269.1m
Chart
NPAT growth %34.7%Outside range high npat growth. 34.7%; 3-period range -23.2% to 24.5%. NPAT growth: 34.7%, above normal range; 3-period mean 0.1%, range -23.2%-24.5%.-23.6%24.5%-22.1%-23.2%62.1%-1.1%-50.5%
Chart
  • HY26 NPAT growth %: Outside range high npat growth. 34.7%; 3-period range -23.2% to 24.5%. NPAT growth: 34.7%, above normal range; 3-period mean 0.1%, range -23.2%-24.5%.
Operating cash flow$279.9m$548.2m$228.7m$443.2m$191.6m$398.2m$146.7m$369.2m
Chart
OCF / EBITDA %199.2%—168.4%116.0%143.5%88.5%104.2%130.9%
Chart
FCF pre-lease$227.2m-$98.9m-$82.9m-$168.2m-$63.9m-$126.9m$117.2m—
Chart
DPS3.8c13.2c11.3c13.2c11.3c13.2c11.3c11.6c
Chart
Payout ratio vs NPAT %5.4%Outside range low payout ratio versus npat. 5.4%; 3-period range 19.7% to 26%. Payout ratio versus NPAT: 5.4%, below normal range; 3-period mean 22.3%, range 19.7%-26.0%.22.7%21.3%16.9%26.0%13.1%19.7%19.1%
Chart
  • HY26 Payout ratio vs NPAT %: Outside range low payout ratio versus npat. 5.4%; 3-period range 19.7% to 26%. Payout ratio versus NPAT: 5.4%, below normal range; 3-period mean 22.3%, range 19.7%-26.0%.
Annual payout ratio vs EPS %—22.7%—16.9%—13.1%—19.1%
Chart
ROE %4.9%7.8%Outside range low roe. 7.8%; 3-period range 11.5% to 16.8%. ROE: 7.8%, below normal range; 3-period mean 13.5%, range 11.5%-16.8%.4.0%11.4%3.8%16.7%5.8%12.3%
Chart
  • FY25 ROE %: Outside range low roe. 7.8%; 3-period range 11.5% to 16.8%. ROE: 7.8%, below normal range; 3-period mean 13.5%, range 11.5%-16.8%.
Net debt$2.1b$2b$1.8b$1.7b—$1.4b——
Chart
Net debt / EBITDA14.65x—13.62x4.46x—3.07x——
Chart
Debtor days106Outside range high debtor days. 106d; 3-period range 51d to 58d. Debtor days: 105.6 days, above normal range; 3-period mean 54.7 days, range 50.8 days-57.6 days.9Outside range high debtor days. 9d; 3-period range 7d to 8d. Debtor days: 9.1 days, above normal range; 3-period mean 7.5 days, range 6.9 days-8.3 days.518567587
Chart
  • FY25 Debtor days: Outside range high debtor days. 9d; 3-period range 7d to 8d. Debtor days: 9.1 days, above normal range; 3-period mean 7.5 days, range 6.9 days-8.3 days.
  • HY26 Debtor days: Outside range high debtor days. 106d; 3-period range 51d to 58d. Debtor days: 105.6 days, above normal range; 3-period mean 54.7 days, range 50.8 days-57.6 days.
Total assets$9.8b$9.2b$8.7b$8.1b$7.4b$6.9b$6.3b$5.8b
Chart

Reference: annolyse.ai/companies/sum

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...
  • FY25 SUM FY: Outside range low revenue growth. 13.1%; 3-period range 14% to 17.5%. Revenue growth: 13.1%, below normal range; 3-period mean 15.9%, range 14.0%-17.5%.

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

More financial metrics

Additional filing-backed metrics for this company. Each point links to the relevant published briefing.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

ROE

Return on equity.

Loading chart...
  • FY25 SUM FY: Outside range low roe. 7.8%; 3-period range 11.5% to 16.8%. ROE: 7.8%, below normal range; 3-period mean 13.5%, range 11.5%-16.8%.

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...

DPS

Dividend per share declared for the period.

Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

Loading chart...
  • HY26 SUM HY: Outside range low payout ratio versus npat. 5.4%; 3-period range 19.7% to 26%. Payout ratio versus NPAT: 5.4%, below normal range; 3-period mean 22.3%, range 19.7%-26.0%.

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...
  • FY25 SUM FY: Outside range high debtor days. 9d; 3-period range 7d to 8d. Debtor days: 9.1 days, above normal range; 3-period mean 7.5 days, range 6.9 days-8.3 days.
  • HY26 SUM HY: Outside range high debtor days. 106d; 3-period range 51d to 58d. Debtor days: 105.6 days, above normal range; 3-period mean 54.7 days, range 50.8 days-57.6 days.

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

Loading chart...

The setup & the reality

FY25 → HY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What FY25 said to watch

Previous analysisFY25Result releasedAnnolyse analysis published

From PBT fell 32.2%; underlying profit rose 13%

No formal FY26 financial targets are supplied in the release context, so this briefing assesses the result against the half-year trajectory rather than guidance. H1 FY25 contributed 47.8% of full-year revenue and 49% of NPAT, which is consistent with the company's slightly second-half-weighted shape and indicates that the H2 cadence broadly followed H1's improved sales momentum.

Management commentary in the half-year release flagged improving sales contract rates and growing stock under contract. The full-year volume outcome (1,560 ORA sales vs. 1,238) is consistent with that signal having carried through H2. What the release does not support is any read on the durability of revaluation gains, which drive a large share of reported IFRS profit and which compressed materially in FY25.

Open questions

Open questions from FY25

  • What was the FY25 investment property fair-value uplift, and how much of the PBT decline does it account for relative to other below-the-line items?
  • Why did the effective tax rate normalise from -4.5% to 7.7%, and is 7.7% representative going forward or itself unusually low?
  • How does management plan to evolve capex intensity, given $647.1m of capex against $361.8m of revenue and another $257.0m of borrowings drawn?
  • What is the trajectory of net debt and gearing as the land bank of around 5,500 units is built out, and at what point does development funding capacity constrain pipeline pace?
  • Is the 24.5 cents full-year dividend sustainable against ROE that has slipped from 11.4% to 7.8% while FCF before leases remains negative?

This briefing cannot assess the components of the investment property fair-value movement, the cost-to-build trajectory by village cohort, or forward unit pricing in either New Zealand or Australia from the disclosures supplied.

Latest result sources

Primary issuer documents used for the HY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.

Current period

Prior comparable period

Half Year Report - 1H25

HY25 / financial report

Media Release - 1H25 Results

HY25 / media release

Results Announcement - 1H25

HY25 / results announcement

Results Presentation - 1H25

HY25 / results presentation

Full-year context

Release context

Outcome of Summerset Annual Meeting

HY25 / commentary

NZX announcement - Summerset investor day presentation

HY26 / commentary

Outcome of Summerset Annual Meeting

HY26 / commentary

Peer context

Retirement living comparison set

These companies share the same curated sub-sector label. Their reporting definitions can still differ, so compare the underlying measures before ranking them.

Archive

Briefing archive

The full chronological archive contains every published result briefing.

Open all 8 result briefings

Get notified when SUM publishes

Get the next Summerset Group Holdings result briefing and five-year history updates by email.